Conference Coverage: BMT Tandem Meetings

Conference Coverage

Tocilizumab shows promise for GVHD prevention

ORLANDO – The interleuken-6 receptor blocker tocilizumab showed promising activity for preventing graft-versus-host disease when added to standard...

Conference Coverage

Post-transplant drug combo eyed for high-risk AML

Azacitadine and valproic acid can be safely coadministered as maintenance therapy after allogeneic stem cell transplant in patients with high-risk...

Conference Coverage

Mixed leukemias can benefit from allo-HST

Allogeneic hematopoietic stem cell transplantation using a matched donor is a valid treatment option–and potential cure–for leukemias with markers...

Conference Coverage

Phase III trial: VZV protects auto-HCT patients

ORLANDO – An inactivated VZV vaccine for adults undergoing autologous hematopoietic stem cell transplantation has proven safe and effective.